Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/11/2012US20120259001 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation
10/11/2012US20120258997 New application of 2-pyrrolidone derivatives
10/11/2012US20120258994 Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
10/11/2012US20120258993 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
10/11/2012US20120258984 5-htp combination therapy
10/11/2012US20120258982 Adamantyl compounds
10/11/2012US20120258981 Process for the Synthesis of Quaternary Amine Compounds
10/11/2012US20120258979 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/11/2012US20120258978 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
10/11/2012US20120258977 Inhibitors of e1 activating enzymes
10/11/2012US20120258975 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
10/11/2012US20120258973 Disubstituted heteroaryl-fused pyridines
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258964 2-heteroaryl carboxamides
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258961 4-amino-1,3-thiazine or oxazine derivative
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258958 Azaindoles useful as inhibitors of jak and other protein kinases
10/11/2012US20120258957 Heterocyclic derivatives
10/11/2012US20120258956 Use of a spirolide, analogues and derivatives for treating and/or preventing pathological conditions linked to the tau and beta-amyloid proteins
10/11/2012US20120258955 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/11/2012US20120258954 ArylSulfonamide Based Matrix Metalloprotease Inhibitors
10/11/2012US20120258952 Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
10/11/2012US20120258951 Novel antiplatelet agent
10/11/2012US20120258950 PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
10/11/2012US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors
10/11/2012US20120258947 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
10/11/2012US20120258946 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
10/11/2012US20120258931 Regimens for Intra-Articular Viscosupplementation
10/11/2012US20120258924 Method of modulating stress-activated protein kinase system
10/11/2012US20120258917 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
10/11/2012US20120258916 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
10/11/2012US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation
10/11/2012US20120258180 Parp inhibitors for the treatment of cipn
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258172 Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258164 Transdermal granisetron
10/11/2012US20120258161 Implantable polymeric device for sustained release of dopamine agonist
10/11/2012US20120258146 Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy
10/11/2012US20120258132 Vagal Nerve-Based Disorders
10/11/2012US20120258130 Vaccination regimen for b-cell vaccines
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258084 Progenitor cells and uses thereof
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258075 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
10/11/2012US20120258041 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2832483A1 Methods and compositions for treating neurodegenerative diseases
10/11/2012CA2832373A1 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
10/11/2012CA2832291A1 Pyrrolo[2,3-d)pyrimidine tropomyosin-related kinase inhibitors
10/11/2012CA2832157A1 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
10/11/2012CA2832113A1 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2831995A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/10/2012EP2508599A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2508204A2 Remedies for diseases caused by vascular contraction or dilation
10/10/2012EP2508194A1 Methods of treating disease with random copolymers
10/10/2012EP2508191A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction
10/10/2012EP2508186A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/10/2012EP2508181A1 Compositions and Methods Of Using (R)-Pramipexole
10/10/2012EP2508179A1 Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/10/2012EP2508178A2 Use of nutritional compositions for preventing disorders
10/10/2012EP2508177A1 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
10/10/2012EP2507245A2 Multicyclic compounds and methods of use thereof
10/10/2012EP2507238A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
10/10/2012EP2507231A1 Indazole derivatives as pi 3 - kinase inhibitors
10/10/2012EP2507225A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
10/10/2012EP2506869A1 Arf6 as a new target for treating alzheimer's disease
10/10/2012EP2506866A2 Treatment of nerve injuries
10/10/2012EP2506845A1 Combination of droloxifene and clopidogrel
10/10/2012EP2506842A2 Formulations, salts and polymorphs of transnorsertraline and uses thereof
10/10/2012EP2506715A1 Method of treatment of cns disorders
10/10/2012EP2506712A1 Morphinan derivatives for the treatment of drug overdose
10/10/2012EP2506709A2 Amantadine compositions and methods of use
10/10/2012CN202477170U Traditional Chinese medicine pillow with functions of building brain and sleeping peacefully
10/10/2012CN1829482B Medicine box for treatment of dependence withdrawal
10/10/2012CN1607957B Modulation of excitable tissue function by peripherally administered erythropoietin
10/10/2012CN1452496B Use of strains of parapox ovis virus against organ fibrosis
10/10/2012CN1371416B Human CTLA-4 antibodies and their uses
10/10/2012CN1359301B Pharmaceutical composition comprising antibody specifically binding epitope in A-beta-10 residual group and its application
10/10/2012CN102725285A (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerati
10/10/2012CN102725284A Compound suitable for the treatment of synucleopathies
10/10/2012CN102724989A Compositions comprising andrographics paniculata and gingko biloba extracts complexed with phospholipids
10/10/2012CN102719443A Carboxyl-terminal specific anti-human amyloid protein monoclonal antibody gene and its encoded polypeptide and application
10/10/2012CN102718870A Insulin bio-sensitizer and application thereof
10/10/2012CN102718857A Denatured protein powder and brain protein hydrolyzate prepared from same
10/10/2012CN102718759A Heterocyclic CETP inhibitors
10/10/2012CN102718758A Quinolinone derivative and application thereof as anti-schizophrenic drug
10/10/2012CN102718748A Compounds having analgesic and/or immunostimulant activity
10/10/2012CN102718730A Methods of synthesis and/or purification of diaminophenothiazinium compounds
10/10/2012CN102718726A (z)-5-benzylidene thiazoline-4-thiazoline derivative as immunomodulator
10/10/2012CN102718710A Morphinan compounds
10/10/2012CN102718703A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities
10/10/2012CN102718676A Agomelatine sulfate and preparation method thereof
10/10/2012CN102718675A Agomelatine methanesulfonic acid complex and preparation method thereof
10/10/2012CN102716493A Copolymer containing amorphous agomelatine, and preparation method, pharmaceutical composition and application thereof
10/10/2012CN102716487A Permeation enhancer for improving transdermal absorption of Ginsenoside-Rd and application thereof
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 1833